Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net earnings	$ 402,353,000	$ 386,071,000
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	24,217,000	23,327,000
Amortization	35,821,000	32,969,000
Deferred tax benefit	(1,766,000)	(3,237,000)
Share-based compensation	8,222,000	9,200,000
Increase (decrease) in cash resulting from changes in:
Trade accounts receivable, net	60,460,000	(4,235,000)
Inventories	47,746,000	(70,353,000)
Other current assets	4,057,000	(15,629,000)
Trade accounts payable	(76,707,000)	4,656,000
Taxes payable	13,249,000	31,390,000
Increase (Decrease) in Other Operating Assets and Liabilities, Net	(97,579,000)	(84,166,000)
Net cash provided by operating activities	420,073,000	309,993,000
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment	412,000	118,000
Purchase of property, plant and equipment	(51,947,000)	(62,391,000)
Proceeds from government funding	1,264,000	25,013,000
Acquisitions	(613,000)	(10,765,000)
Payments for (Proceeds from) Derivative Instrument, Investing Activities	(14,414,000)	7,372,000
Net cash used in investing activities	(65,298,000)	(40,653,000)
Cash flows from financing activities:
Proceeds from borrowings	1,080,921,000	1,239,813,000
Repayments of borrowings	(958,731,000)	(952,559,000)
Proceeds from stock option exercises	19,087,000	17,710,000
Repurchases of common stock	(499,999,000)	(549,999,000)
Payment for Contingent Consideration Liability, Financing Activities	5,626,000	7,912,000
Proceeds from (Payments for) Other Financing Activities	(714,000)	(382,000)
Net cash used in financing activities	(365,062,000)	(253,329,000)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(2,105,000)	(5,126,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(12,392,000)	10,885,000
Beginning of period	95,966,000	98,564,000
End of period	83,574,000	109,449,000
Cash and cash equivalents:	$ (12,392,000)	$ 10,885,000